Clearbridge Investments, LLC Lexicon Pharmaceuticals, Inc. Transaction History

Clearbridge Investments, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$1.2 - $6.66 $1.76 Million - $9.75 Million	-1,463,262 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$5.35 - $7.11 $915,556 - $1.22 Million	171,132 Added 13.24%	1,463,262 $0
Q1 2019 May 15, 2019	BUY	$4.36 - $7.94 $185,474 - $337,767	42,540 Added 3.4%	1,292,130 $7.18 Million
Q4 2018 Feb 14, 2019	SELL	$6.15 - $10.51 $284,868 - $486,823	-46,320 Reduced 3.57%	1,249,590 $8.3 Million
Q3 2018 Nov 14, 2018	BUY	$10.32 - $13.06 $13.4 Million - $16.9 Million	1,295,777 Added 974268.44%	1,295,910 $13.8 Million
Q2 2018 Aug 14, 2018	BUY	$7.8 - $13.69 $85 - $150	11 Added 9.02%	133 $2,000
Q4 2017 Feb 14, 2018	SELL	$8.77 - $12.28 $21,328 - $29,864	-2,432 Reduced 95.22%	122 $1,000
Q3 2017 Nov 14, 2017	BUY	$12.17 - $16.3 $3,711 - $4,971	305 Added 13.56%	2,554 $31,000
Q2 2017 Aug 14, 2017	BUY	N/A	2,249	2,249 $37,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $157M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Clearbridge Investments, LLC with notifications on news.